Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 43,22
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Anbieter: Books Puddle, New York, NY, USA
Zustand: New.
Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. Enhancing Irbesartan Bioavailability via Solid Dispersion | Optimizing Dissolution of Irbesartan Through Advanced Solid Dispersion Techniques | Rashmitha Vallala (u. a.) | Taschenbuch | Englisch | 2024 | LAP LAMBERT Academic Publishing | EAN 9786208119713 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.
Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Anbieter: PBShop.store US, Wood Dale, IL, USA
PAP. Zustand: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
EUR 45,34
Anzahl: Mehr als 20 verfügbar
In den WarenkorbPAP. Zustand: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 60,41
Anzahl: 4 verfügbar
In den WarenkorbZustand: New. Print on Demand.
Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing Sep 2024, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 84 pp. Englisch.
Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: New. PRINT ON DEMAND.
Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing Sep 2024, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Hypertension is a prevalent condition, especially in those over 50, and can lead to severe cardiovascular complications. Irbesartan, an angiotensin II receptor blocker (ARB), is commonly used to manage hypertension, but its low aqueous solubility (1 ¿g/ml) limits its bioavailability. This study aimed to improve Irbesartan's solubility through solid dispersions using carriers like ß-cyclodextrin, HPMC K4M, PEG4000, and Gelatin. ß-cyclodextrin showed the greatest enhancement in solubility, as confirmed by phase solubility studies. Characterization through DSC and SEM indicated the drug's transformation from crystalline to amorphous form, improving dissolution. FTIR studies confirmed no interaction between the drug and carriers. In vitro dissolution tests revealed that ß-cyclodextrin (1:9) formulations significantly increased the dissolution rate compared to pure Irbesartan and other carriers. Thus, using ß-cyclodextrin in solid dispersions effectively enhances Irbesartan's solubility and therapeutic potential in treating hypertension.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 84 pp. Englisch.
Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Hypertension is a prevalent condition, especially in those over 50, and can lead to severe cardiovascular complications. Irbesartan, an angiotensin II receptor blocker (ARB), is commonly used to manage hypertension, but its low aqueous solubility (1 ¿g/ml) limits its bioavailability. This study aimed to improve Irbesartan¿s solubility through solid dispersions using carriers like ¿-cyclodextrin, HPMC K4M, PEG4000, and Gelatin. ¿-cyclodextrin showed the greatest enhancement in solubility, as confirmed by phase solubility studies. Characterization through DSC and SEM indicated the drug¿s transformation from crystalline to amorphous form, improving dissolution. FTIR studies confirmed no interaction between the drug and carriers. In vitro dissolution tests revealed that ¿-cyclodextrin (1:9) formulations significantly increased the dissolution rate compared to pure Irbesartan and other carriers. Thus, using ¿-cyclodextrin in solid dispersions effectively enhances Irbesartan¿s solubility and therapeutic potential in treating hypertension.